Founders hiring a fractional CMO for the first time often have one question they find awkward to ask: what should I actually see, and when? Without an answer, every month feels like a leap of faith, and engagements end early for the wrong reasons or run on too long for the wrong reasons. This article sets out a realistic month-by-month view of the first six months, written from the buyer's side. It describes outputs, the concrete things you should be able to see and use, rather than promised results, because results depend on your market, budget and sales cycle. It complements the article on the first 90 days, which describes the same period from the operator's side.
Why outputs come before outcomes
Revenue is a lagging indicator. Marketing changes made this month affect leads within weeks, opportunities within your sales cycle and revenue after that. In a business with a three-month sales cycle, a good decision in month two may not show up in revenue until month five or later. So the first months should be judged on outputs and leading indicators: is the diagnosis right, is the tracking accurate, are leads being qualified consistently, is money moving from what does not work to what does. If those are in place, outcomes follow. If you judge the first quarter on revenue alone, you will reward luck and punish good work that has not had time to show. The scorecard article on fractional CMO KPIs by ARR stage covers which metrics to watch at 30, 90 and 180 days.
Month 1: access, diagnosis and a written plan
The first month is about seeing clearly. Expect the fractional CMO to request access to ad accounts, analytics, tag manager, the CRM, the website, agency reports and past budgets, and to interview the founder, sales lead, marketing team and agencies. By the end of the month you should have a written diagnosis: where the funnel leaks, what the data can and cannot be trusted for, which spend is unconnected to pipeline, and what the main constraint on growth is. It should be followed by a prioritised 90-day plan with owners. Warning signs in month one: no written output, a generic plan that could apply to any company, or immediate large spend increases before the measurement has been checked.
Month 2: measurement and definitions you can trust
Month two usually fixes the foundations the diagnosis exposed. Common work: correcting conversion tracking, setting up consistent UTM tagging, connecting ad platforms to the CRM so that qualified leads and closed deals can be traced back to source, and agreeing written definitions of a marketing qualified lead, a sales qualified lead and an opportunity with the sales lead. You should see a simple dashboard that both marketing and sales accept, even if it is rough. This month can feel slow because little looks different from outside. It is the month that makes every later decision possible, so resist pressure to skip it.
Months 3 and 4: reallocation and agency setup
With trustworthy numbers, the work shifts to allocation. Expect decisions to pause or cut channels and campaigns that do not produce qualified pipeline, to put more behind those that do, and to restructure campaigns around the stages that matter rather than around clicks or form fills. If agencies are involved, expect clearer briefs, revised scopes and possibly a change of provider where performance or ownership of accounts is a problem. You should also see the beginnings of a content, campaign or launch calendar tied to the plan. By the end of month four, the cost per qualified lead or opportunity should be trending in the right direction, even if revenue has not moved yet.
Months 5 and 6: rhythm, team and early pipeline evidence
By months five and six the function should run on a rhythm: a weekly performance review, a monthly report to the founder or leadership team and a quarterly plan. If hiring was part of the mandate, expect job descriptions, interviews or a first hire in place. You should see pipeline evidence: more qualified opportunities, a better conversion rate between stages or a lower cost per opportunity, depending on what the diagnosis targeted. In shorter sales cycles you may also see revenue impact. This is the right point for a formal review of the engagement: what was planned, what was delivered, what changed in the numbers and what the next six months should focus on.
Month-by-month output checklist
Use this table at each monthly check-in. Adjust the timing to your sales cycle; the order rarely changes.
| Month | Outputs you should see | Question to ask |
|---|---|---|
| 1 | Access granted, stakeholder interviews, written diagnosis, 90-day plan | What is the single biggest constraint, and how do you know? |
| 2 | Tracking fixed, UTM rules, CRM source fields, lead definitions agreed, first dashboard | Which numbers can we now trust that we could not before? |
| 3 | Spend reallocated, low performers paused, agency briefs rewritten | What did we stop, and what did it free up? |
| 4 | Campaign and content calendar, cost per qualified lead trending | Is cost per qualified opportunity moving, and why? |
| 5 | Weekly and monthly reporting rhythm, hiring plan or first hire | Could the team run this rhythm without you for a month? |
| 6 | Six-month review, pipeline evidence, next-half plan | What would you change in the next six months, and what will you stop? |
What you should be doing as the founder
The engagement also depends on you. Grant access within the first week, because waiting for logins is one of the most common early delays. Attend the monthly review and read the reports before it. Back the decisions you agreed to delegate, especially when they mean ending an agency relationship or pausing a channel you like. Bring sales into the definitions work in month two; if the sales lead does not agree to the lead definitions, the dashboard will not be trusted. And raise concerns early. A fractional CMO cannot fix what they do not know is bothering you, and most problems are easier to resolve in month two than in month five.
Warning signs at the six-month mark
By six months, these signals suggest the engagement is not working: no written plan or the plan was never revisited; the same tracking problems still exist; spend has grown without a matching rise in qualified pipeline; agencies still take direction from the founder rather than the fractional CMO; reports describe activity such as posts published and campaigns launched without connecting them to pipeline; and nobody on the team could explain the strategy. If several apply, have a direct conversation about mandate, access and time. Sometimes the cause is on the company side, such as missing access or overruled decisions. The article on signs a fractional CMO engagement is not working covers how to diagnose and fix this.
How the timeline shifts by business model
The sequence above holds for most companies, but the emphasis changes. In a D2C brand with short purchase cycles, reallocation in months three and four can show up in revenue within weeks, so the six-month review can weigh contribution margin and return on ad spend more heavily. In a B2B company with long sales cycles and several decision makers, the same changes take longer to reach revenue, so pipeline created, stage conversion and meeting quality carry more weight at six months. In a services firm that depends on referrals, early work often focuses on capturing and following up enquiries and building a repeatable source beyond the founder's network, which takes time to compound. Agree at the start which measures matter most for your model, so that the six-month review compares like with like.
FAQ
Not as the main measure. Revenue lags behind marketing changes by at least your sales cycle. Judge the first quarter on diagnosis quality, tracking accuracy, lead definitions and cost per qualified opportunity.
A written diagnosis that names the main constraint on growth and the evidence for it, followed by a prioritised 90-day plan with owners. Everything else depends on getting this right.
Because it fixes measurement and definitions, which are invisible from outside. Skipping it means every later decision rests on numbers nobody trusts.
Hold light monthly check-ins and a formal review at around six months, comparing what was planned, what was delivered and what changed in the numbers.
The order stays the same, but revenue evidence arrives later. In long cycles, weight pipeline and stage conversion more heavily in the six-month review.